Skip to main content

MoneyWorks4Me

Vivanza Biosciences - Quaterly Results

31 Jan 2025 Evaluate
The Sales for the quarter ended December 2024 of Rs. 7.62 million declined by -77.36% from Rs. 33.66 millions.The company reported a drastic decline of -79.67% in the quarter ended December 2024 to Rs. 0.37  millions from Rs. 1.82 millions  .Operating profit for the quarter ended December 2024 decreased to 1.28 millions as compared to 2.85 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 7.62 33.66 -77.36 27.73 121.14 -77.11 144.13 142.07 1.45
Other Income 0.10 0.18 -44.44 0.15 0.84 -82.14 0.54 3.87 -86.05
PBIDT 1.28 2.85 -55.09 5.51 10.19 -45.93 8.54 11.09 -22.99
Interest 0.87 1.02 -14.71 2.72 3.21 -15.26 4.13 4.18 -1.20
PBDT 0.41 1.83 -77.60 2.79 6.98 -60.03 4.41 6.91 -36.18
Depreciation 0.04 0.01 300.00 0.11 0.03 266.67 0.12 0.03 300.00
PBT 0.37 1.82 -79.67 2.68 6.95 -61.44 4.29 6.88 -37.65
TAX 0.00 0.00 0.00 0.00 0.00 0.00 1.12 1.18 -5.08
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00
PAT 0.37 1.82 -79.67 2.68 6.95 -61.44 3.17 5.70 -44.39
Equity 40.00 40.00 0.00 40.00 40.00 0.00 40.00 40.00 0.00
PBIDTM(%) 16.80 8.47 98.39 19.87 8.41 136.22 5.93 7.81 -24.09
Peers
Company Name CMP
Redington 334.30
Adani Enterprises 2694.30
Amrapali Industries 32.05
Maxgrow India 164.55
Rashi Peripheral 638.05
View more..